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ABSTRACT
The GlycoViewer (http://www.systemsbiology.org
.au/glycoviewer) is a web-based tool that can visu-
alize, summarize and compare sets of glycan struc-
tures. Its input is a group of glycan structures; these
can be entered as a list in IUPAC format or via a
sugar structure builder. Its output is a detailed
graphic, which summarizes all salient features of
the glycans according to the shapes of the core
structures, the nature and length of any chains,
and the types of terminal epitopes. The tool can
summarize up to hundreds of structures in a single
figure. This allows unique, high-level views to be
generated of glycans from one protein, from a cell,
a tissue or a whole organism. Use of the tool is
illustrated in the analysis of normal and disease-
associated glycans from the human glycoproteome.
INTRODUCTION
Glycomics is the study of all glycans from a cell, tissue or
system. Large numbers of glycan structures are frequently
reported in research manuscripts, predominantly
determined by mass spectrometry. Increasingly, these are
captured in structure repositories and high-quality curated
databases, such as KEGG glycan, GlycomeDB and
GlycoSuiteDB (1–3). Whilst there are thousands of struc-
tures in these databases, it has been challenging to
combine and visualize these data in a simple fashion.
This has prevented the generation of holistic views of
the glycome, at the level of a cell, tissue or whole
organism. Current depictions of glycans, including the
Oxford and Consortium for Functional Glycomics
(CFG) schema, are tailored to represent single 2D struc-
tures and are not designed to describe families of struc-
tures. KEGG composite structure maps (1) summarize
structure and pathway data, but are challenging to inter-
pret. Furthermore, they are not designed to compare two
or more sets of glycan structures or those from diﬀerent
levels of the glycome. Here we describe the GlycoViewer
tool, a means by which the glycome is given a single rep-
resentation. This provides a unique, high-order view,
permitting global analysis and comparison of glycomic
data.
MATERIALS AND METHODS
To build a single representation of the glycome, the
features contributing most to the variation between struc-
tures had to be deﬁned. An evaluation of all human glycan
structures from GlycomeDB (2), in the context of known
glycosylation pathways, revealed that N- and O-linked
structures could be categorized using just three criteria:
(i) the type and shape of the core structure, (ii) the
nature and length of any chain, and (iii) the nature of
any terminal epitopes (e.g. sialylation, A or B antigen).
The relationships between these criteria were also
captured.
To summarize a set of glycan structures, these criteria
are applied systematically. Each input structure is tra-
versed from the reducing terminus to non-reducing
termini and each of the criteria, above, are evaluated
against each of the residues. A decision is made to
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Statistics describing the number of structures that have
particular features (e.g. chain types or terminal epitopes)
are calculated. Structures from any set that appear incom-
plete or erroneous, which are inconsistent with the criteria,
are removed. The ﬁnal high conﬁdence set of structures is
used to build a composite structure, from the union of all
supplied structures. Separate composite structures are
built for N- and O-linked sugars. To visualize these com-
posite structures, a modiﬁed CFG schema is used to
show the criteria of shape, nature and length, and
terminal epitopes. Annotations to represent the statistics
are also built into the graph. Histograms to quantify
branching are shown alongside, together with names of
any branch types.
The summarizing process has been built into the
GlycoViewer tool (http://www.systemsbiology.org.au/
glycoviewer). Lists containing up to hundreds of struc-
tures can be submitted, for example from databases such
as GlycomeDB or GlycoSuiteDB (2,3). Structures must
adhere to IUPAC nomenclature. Alternatively, a structure
builder is supplied so lists can be constructed as required
and then analysed. The tool is freely available and has no
login requirement. Detailed instructions on the interpret-
ation of the tool’s output are given on the web site, on the
page titled ‘Interpreting the Output’ and are given here as
Supplementary Data.
USAGE
We give two examples to show how the GlycoViewer can
summarize, analyse and compare glycomic data. As a ﬁrst
example, the tool was used to analyse all known human
N-linked structures from the glycome of healthy patients,
as documented in the GlycoSuite database (3). These
structures were obtained by retrieving all 3183 structures
for Homo sapiens and ﬁltering to remove structures
associated with disease, a recombinant system or cell line
and those which were O-linked. Figure 1 summarizes 640
structures to show all monosaccharides present, branching
properties of the N-linked structures, lengths of each
chain and the degree of sialylation and fucosylation.
Qualitative features of the glycome are given and
semi-quantitative measurements show the frequency of
particular residues in structures. The representation high-
lights speciﬁc features of large sets of structures. For
the 640 structures, it is easily seen that all chain extensions
are Type II, with the majority of structures being
bi-antennary (labelled X and Y in Figure 1). The bisecting
GlcNAc (labelled Z) is mutually exclusive to a b1–6
GlcNAc (labelled V) linked to the Man a1–6 branch.
The latter feature has recently been reported elsewhere
(4) and has been attributed to b1–4N-acetylgluco-
saminyltransferase III suppressing b1–4N-acetylglucos-
aminyltransferase V. The absence of b1-4 linked
GlcNAc on the Man a1–6 branch of the N-linked core,
also clear in the ﬁgure, has also been previously noted (5).
The GlycoViewer enabled these features to be discerned in
a single graphic; a one-by-one analysis of the entire
structure set would have been laborious, and may not
have provided the same high-level insights.
As a second example, sets of O-linked glycans from two
biological states are compared: those from cancerous
human tissue (98 structures) and human cancer cell lines
(63 structures). The tool facilitates a side by side analysis,
with two summary representations (Figure 2). Most
striking is the presence of Type I chains on tissue-derived
glycoproteins and their complete absence in cell line-
derived glycoproteins. Tissue-derived proteins also show
increased fucosylation and concomitant decrease in
sialylation as compared to cell line-derived glycans. Our
tool also revealed other features of the tissue-derived
glycans. The presence of the core b1–3 GlcNAc (labelled
Z in Figure 2) is mutually exclusive to the presence of core
b1–6 GlcNAc (labeled Y), precluding the existence of core
IV structures. Core b1–3 GlcNAc (Z) is also mutually
exclusive to the presence of the core b1–3 Gal (W,X);
this is to be expected as they share the same linkage
with the core GalNAc. It is interesting to note that this
approach, which facilitated the comparison of two bio-
logical states, could also be used to compare the glycans
from two or more proteins or even the glycome from two
or more species.
DISCUSSION AND CONCLUSION
The GlycoViewer tool, described here, helps reveal the
complexities of the glycome. It allows small or large sets
of glycan structures to be analysed and compared. Results
are reported in a single, comprehensive ﬁgure. Qualitative
and semi-quantitative aspects are highlighted in the
context of structures and graphed in a series of analytical
histograms. We believe the tool can form a logical
endpoint in an analysis pipeline for glycomic data and
has potential to provide holistic insights that are otherwise
diﬃcult to discern. It provides a single, common interface
to the glycome at the level of the cell, the tissue or entire
organism. One major consideration in the use of our tech-
nology, and similar approaches that examine large sets of
structures, is the quality of input data. Whilst there are
numerous databases of glycan structures in use, the
quality of structures in each database and the biological
descriptors are variable. In part, this reﬂects the challenge
of curating structural information, the diﬃculties in un-
ambiguous determination of structures even by mass spec-
trometry and the need for an international co-ordinated
eﬀort in this regard. In the analyses presented here, we
used structures from the GlycoSuiteDB database (3),
recently released into the public domain
(http://glycosuitedb.expasy.org). This is one of the few
databases which represent structures in IUPAC format.
Whilst this database does not contain a complete
glycome for any species, it is suﬃciently diverse and
curated to allow complex queries and analyses to be
made and high-level features of glycome to be discerned.
The eﬃcacy and utility of the GlycoViewer tool will
improve as glycan structure databases become increas-
ingly complete.
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Figure 1. The composite structure for 640N-glycans, derived from human tissue. (A) Residues in all structures have CFG icons and colours with
saturation of colour representing the abundance of a residue in the set of structures. Residues may be annotated to show the number of structures in
the database containing a residue (number in bottom right circle), number of publications reporting the residue in the structure (number in bottom
left circle) and a label (V, W, X, Y, Z) that identiﬁes a branch (capital letter in top right circle). Linkages between core residues are labelled with
anomer and ring substitution position whereas linkages in chains have coloured linking connections (explained in the key to the ﬁgure). Terminal
epitopes upon chains are represented using arcs (NeuAc) and wedges (Fucose). Arcs show the degree of sialylation of a residue in a set of structures;
the degree of ﬁll in the arc correlates with the degree of sialylation; the two possible positions of sialylation (a2–3 and a2–6) are positioned below and
above the residue, respectively. Wedges show the degree of fucosylation, with full fucosylation represented by a full wedge. A downward-facing
wedge is a fucose in an a1–2 linkage, a left-facing wedge represents a1–3 linkage and an upward facing wedge represents an a1–4 linkage. Core
fucosylation is shown by a standard symbol. The annotation inside the residues of a chain (e.g. Sd
a, A or B) indicate terminal epitopes comprised of
Gal and GalNAc residues. (B) Histograms measuring the overall branching characteristics of the set of glycan structures. One histogram is shown per
labelled branch (i–v), with each histogram comparing the number of times other branches occur with respect to that branch. Thus the histogram for
branch V (i) shows that structures containing branch V can contain branches W–Y but do not contain branch Z. The overall degree of branching in
the set of glycans is shown in a second type of histogram (vi), where the proportion of structures in the set containing 0, 1..., n branches is graphed.
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Figure 2. Comparison of O-linked glycan structures from human cancer cell lines (98 structures) and cancerous human tissues (63 structures). This
comparison was done by entering the two sets of structures, as list 1 and list 2, and using the ‘compare list’ function of GlycoViewer. Note that in
this ﬁgure, the histograms compare the overall branching in the two sets of glycans. Bars going up represent branching in the human cancer tissues;
bars going down represent branching in cancer-related cell lines.
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